Acumen Pharmaceuticals, Inc. (ABOS) Operating cash flow 2020–2025
Acumen Pharmaceuticals, Inc. (ABOS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$115.5MFY2025 · since FY2020: -$7.5M → -$115.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$115.5M | -34.0% |
| FY2024 | -$86.2M | -100.2% |
| FY2023 | -$43.1M | -22.5% |
| FY2022 | -$35.2M | -95.7% |
| FY2021 | -$18.0M | -141.1% |
| FY2020 | -$7.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice